Sarepta Therapeutics | SRPT - Market Capitalization


Sarepta Therapeutics reported $1.68B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Eli Lilly USD 1.13T 260.54B Jun/2026
Gilead Sciences USD 196.01B 39.15B Oct/2026
Incyte USD 22.65B 3.92B Jun/2026
Insmed USD 14.12B 8.99B Oct/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
PTC Therapeutics USD 4.83B 1.97B Oct/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026